GSE190384,GSE190386 6 V 8 FULVESTRANT HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE190384,GSE190386 6 V 8 FULVESTRANT HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE190384,GSE190386 6 V 8 FULVESTRANT HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE190384,GSE190386 6 V 8 FULVESTRANT HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE190384,GSE190386 6 V 8 FULVESTRANT HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

STIMATE-MUSTN1 readthrough

Gene

ZNF593 opposite strand

Gene

cytochrome c oxidase assembly factor 4 homolog

Gene

heterogeneous nuclear ribonucleoprotein L like

Gene

DiGeorge syndrome critical region gene 6 like

Gene

synaptogyrin 1

Gene

estrogen receptor binding site associated antigen 9

Gene

synaptotagmin 12

Gene

ficolin 3

Gene

splicing regulatory glutamic acid and lysine rich protein 1

  • Gene

    STIMATE-MUSTN1 readthrough


  • Gene

    ZNF593 opposite strand


  • Gene

    cytochrome c oxidase assembly factor 4 homolog


  • Gene

    heterogeneous nuclear ribonucleoprotein L like


  • Gene

    DiGeorge syndrome critical region gene 6 like



  • Gene

    estrogen receptor binding site associated antigen 9


  • Gene

    synaptotagmin 12



  • Gene

    splicing regulatory glutamic acid and lysine rich protein 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.